Phase Ib Study of Efsubaglutide Alfa Injection in Obese Adolescents

Clinical trial NCT07693426 · RECRUITING

Trial details

NCT number: NCT07693426
Sponsor: Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Adolescence Obesity

Start date: 2026-07-16
Primary completion: 2027-04-30
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.